NCT01950650View on ClinicalTrials.gov

GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus

CompletedOBSERVATIONAL
Enrollment

1,800

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

No treatment given

Survey conducted through computer-assisted telephone interviewing.

BEHAVIORAL

survey

Survey conducted via the Internet.

Trial Locations (10)

28033

Novo Nordisk Investigational Site, Madrid

34335

Novo Nordisk Investigational Site, Istanbul

55127

Novo Nordisk Investigational Site, Mainz

92932

Novo Nordisk Investigational Site, Paris La Défense Cedex

100004

Novo Nordisk Investigational Site, Beijing

119330

Novo Nordisk Investigational Site, Moscow

560001

Novo Nordisk Investigational Site, Bangalore

1000005

Novo Nordisk Investigational Site, Tokyo

08540

Novo Nordisk Investigational Site, Princeton

RH11 9RT

Novo Nordisk Investigational Site, Crawley

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01950650 - GAPP 1 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Diabetes Mellitus | Biotech Hunter | Biotech Hunter